SE468882B - Anvaendning av erytro-dops foer framstaellning av ett laekemedel foer behandling av psykomotorisk roerelse - Google Patents
Anvaendning av erytro-dops foer framstaellning av ett laekemedel foer behandling av psykomotorisk roerelseInfo
- Publication number
- SE468882B SE468882B SE8404715A SE8404715A SE468882B SE 468882 B SE468882 B SE 468882B SE 8404715 A SE8404715 A SE 8404715A SE 8404715 A SE8404715 A SE 8404715A SE 468882 B SE468882 B SE 468882B
- Authority
- SE
- Sweden
- Prior art keywords
- dops
- erythro
- movement
- mice
- administered
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP58175581A JPS6067420A (ja) | 1983-09-22 | 1983-09-22 | 精神運動興奮抑制剤 |
| CA000452844A CA1225598A (en) | 1983-09-22 | 1984-04-26 | Pharmaceutical composition and method for treatment of psychomotor excitement |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| SE8404715D0 SE8404715D0 (sv) | 1984-09-20 |
| SE8404715L SE8404715L (sv) | 1985-03-23 |
| SE468882B true SE468882B (sv) | 1993-04-05 |
Family
ID=25670371
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE8404715A SE468882B (sv) | 1983-09-22 | 1984-09-20 | Anvaendning av erytro-dops foer framstaellning av ett laekemedel foer behandling av psykomotorisk roerelse |
Country Status (10)
| Country | Link |
|---|---|
| BE (1) | BE900654A (de) |
| CH (1) | CH664493A5 (de) |
| DE (1) | DE3433675A1 (de) |
| FR (1) | FR2552327B1 (de) |
| GB (1) | GB2146899B (de) |
| IT (1) | IT1175863B (de) |
| MX (1) | MX167915B (de) |
| NL (1) | NL8402850A (de) |
| NZ (1) | NZ209514A (de) |
| SE (1) | SE468882B (de) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH580059A5 (de) * | 1973-08-22 | 1976-09-30 | Hoffmann La Roche | |
| US3920728A (en) * | 1973-08-22 | 1975-11-18 | Hoffmann La Roche | Separation and resolution of isomeric forms of 3-(3,4-dihydroxy-phenyl)-serine |
| NL7700945A (nl) * | 1976-02-13 | 1977-08-16 | Merck & Co Inc | Werkwijze voor het bereiden van bloeddruk- verhogende preparaten. |
| JPS52125630A (en) * | 1976-04-14 | 1977-10-21 | Kyowa Hakko Kogyo Co Ltd | Antiperkinson drugs containing l-threo-3,4-dihydroxyphenylserine |
| JPS56104815A (en) * | 1980-01-23 | 1981-08-20 | Sumitomo Chem Co Ltd | Remedy for peripheral orthostatic hypotension |
| JPS5852219A (ja) * | 1981-09-22 | 1983-03-28 | Sumitomo Chem Co Ltd | パ−キンソン病治療剤 |
-
1984
- 1984-09-12 NZ NZ20951484A patent/NZ209514A/en unknown
- 1984-09-13 FR FR8414040A patent/FR2552327B1/fr not_active Expired
- 1984-09-13 DE DE19843433675 patent/DE3433675A1/de not_active Ceased
- 1984-09-17 IT IT2268584A patent/IT1175863B/it active
- 1984-09-17 NL NL8402850A patent/NL8402850A/nl not_active Application Discontinuation
- 1984-09-19 GB GB08423725A patent/GB2146899B/en not_active Expired
- 1984-09-20 SE SE8404715A patent/SE468882B/sv not_active Application Discontinuation
- 1984-09-21 CH CH454184A patent/CH664493A5/de not_active IP Right Cessation
- 1984-09-21 BE BE6/48009A patent/BE900654A/fr not_active IP Right Cessation
- 1984-09-24 MX MX841284A patent/MX167915B/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GB2146899B (en) | 1987-11-25 |
| CH664493A5 (de) | 1988-03-15 |
| SE8404715L (sv) | 1985-03-23 |
| SE8404715D0 (sv) | 1984-09-20 |
| BE900654A (fr) | 1985-03-21 |
| IT1175863B (it) | 1987-07-15 |
| NZ209514A (en) | 1988-03-30 |
| FR2552327A1 (fr) | 1985-03-29 |
| NL8402850A (nl) | 1985-04-16 |
| FR2552327B1 (fr) | 1988-01-15 |
| GB2146899A (en) | 1985-05-01 |
| DE3433675A1 (de) | 1985-04-11 |
| GB8423725D0 (en) | 1984-10-24 |
| MX167915B (es) | 1993-04-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Mueller et al. | Neuroleptic malignant syndrome: successful treatment with bromocriptine | |
| US9271966B2 (en) | Pharmaceutical compositions for the treatment of movement disorders | |
| Chase et al. | Parkinson's disease: Modification by 5‐hydroxytryptophan | |
| US20060276412A1 (en) | Methods and compositions for managing psychotic disorders | |
| US20050282911A1 (en) | Memantine for the prevention or reduction of suicidality and for treatment of major depression associated with suicidality | |
| US9504665B2 (en) | High-dose glycine as a treatment for obsessive-compulsive disorder and obsessive-compulsive spectrum disorders | |
| BRPI0618918A2 (pt) | composições e métodos para aumentar a sensibilidade à insulna | |
| JPH0245425A (ja) | 脳神経障害治療用薬剤 | |
| US4529603A (en) | Pharmaceutical composition and method for treatment of psychomotor excitement | |
| Fann et al. | Effect of iprindole on amine uptake in man | |
| EP1171114A1 (de) | Verfahren zur behandlung von inkontinenz | |
| SE468882B (sv) | Anvaendning av erytro-dops foer framstaellning av ett laekemedel foer behandling av psykomotorisk roerelse | |
| Hall et al. | Rapid deterioration in patients with parkinsonism following tryptophan‐pyridoxine administration | |
| Steingard et al. | Neuroleptic malignant syndrome: review of experience with children and adolescents | |
| Engber et al. | Excitatory amino acid receptor antagonists modify regional cerebral metabolic responses to levodopa in 6-hydroxydopamine-lesioned rats | |
| Charrabarti et al. | Effects on platelet stickiness and fibrinolysis of phenformin combined with ethyloestrenol or stanozolol | |
| Kemali et al. | Relationship between CSF noradrenaline levels, C‐EEG indicators of activation and psychosis ratings in drug‐free schizophrenic patients | |
| US6713493B2 (en) | Use of nicergoline in the treatment of spasticity | |
| Kubota et al. | Steroid-responsive chronic cerebellitis with positive glutamate receptor δ2 antibody | |
| US6992109B1 (en) | Method for the treatment of incontinence | |
| Bukoski et al. | Traumatic brain injury does not alter cerebral artery contractility | |
| MXPA06014907A (es) | Uso de acetil l-carnitina para preparacion de medicina para tratamiento de dolor neuropatico en pacientes diabeticos. | |
| Gordon et al. | Subacute necrotising encephalomyelopathy in three siblings | |
| WO2000061234A1 (en) | Combinations of gaba analogs and tricyclic compounds to treat depression | |
| EP4257147A1 (de) | Augentropfen zur hemmung der myopieprogression bei kindern und screening-verfahren für einen hemmer der myopieprogression bei kindern |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NAV | Patent application has lapsed |
Ref document number: 8404715-8 Effective date: 19930512 |